Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Windtree Therapeutics Inc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 12 | 9 | −3 |
| Shares | 269.9K | 674.6K | +404.7K (+149.9%) |
| Value | $194.1K | $238.8K | +$44.7K (+23.0%) |
New holders (1)
Institutions that held Windtree Therapeutics Inc at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 608,272 | $215.3K | 0.00% |
Sold out (4)
Institutions that held Windtree Therapeutics Inc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Alyeska Investment Group, L.P. | 136,518 | $98.2K |
| Virtu Financial LLC | 38,877 | $28.0K |
| Morgan Stanley | 2 | $1 |
| Parallel Advisors, LLC | 1 | $1 |